Trademark: 87219648
Word
IMREJUV
Status
Dead
Status Code
606
Status Date
Monday, June 18, 2018
Serial Number
87219648
Mark Type
4000
Filing Date
Friday, October 28, 2016
Published for Opposition
Tuesday, September 19, 2017
Abandoned Date
Monday, June 18, 2018

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
The wording "IMREJUV" has no meaning in a foreign language.

Trademark Events
Jun 18, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jun 18, 2018
Abandonment - No Use Statement Filed
Nov 14, 2017
Noa E-Mailed - Sou Required From Applicant
Sep 19, 2017
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2017
Published For Opposition
Aug 30, 2017
Notification Of Notice Of Publication E-Mailed
Aug 14, 2017
Approved For Pub - Principal Register
Aug 14, 2017
Teas/Email Correspondence Entered
Aug 14, 2017
Correspondence Received In Law Office
Aug 14, 2017
Assigned To Lie
Jul 18, 2017
Teas Response To Office Action Received
Jan 30, 2017
Notification Of Priority Action E-Mailed
Jan 30, 2017
Priority Action E-Mailed
Jan 30, 2017
Priority Action Written
Jan 28, 2017
Assigned To Examiner
Nov 2, 2016
New Application Office Supplied Data Entered In Tram
Nov 1, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24